docs (beta)

42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen 
=== VARIABELEN ===
Array
(
    [defid] => VWS-WOO-08-1259977
    [request_id] => 
)

=== SQL LOG ===
Geen SQL queries.
Huidig document record 
Array
(
    [id] => c5f4e77c-5399-49d7-856b-694c6de1cc37
    [Document ID] => 1259977
    [Document naam] => FW: HMA survey on AZ vaccine and MABs
    [Bestandsnaam] => 
    [Beoordeling] => 
    [Beoordelingsgrond] => 
    [Toelichting] => 
    [Publieke link] => 
    [Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/document/VWS-WOO-08-1259977
    [Opgeschort] => 
    [Definitief ID] => VWS-WOO-08-1259977
    [Status] => 
    [FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo
    [DocumentPublicationDate] => 6 april 2021
    [DocumentStatusCheckedDate] => 
    [DocumentStatusCheckedResult] => 
    [SourceFileType] => 
    [Tags] => 
    [Besluit] => 
    [ModifiedDate] => 2025-09-22 08:19:41
    [DeletedDate] => 
    [BesluitURL] => 
    [CreatedDate] => 2025-06-19 18:31:59
    [DocumentDownloadLink] => 
    [DigestLaatsteControleDatum] => 2025-09-22 08:19:41
)

Document: VWS-WOO-08-1259977

Pagina 1 preview
Klik om te vergroten

Document correcties

Geregistreerde datum: 20210406

Geregistreerde documentnaam: FW: HMA survey on AZ vaccine and MABs

Document metadata

Metadata tonen (25 velden)
VeldWaarde
idc5f4e77c-5399-49d7-856b-694c6de1cc37
Document ID1259977
Document naamFW: HMA survey on AZ vaccine and MABs
Bestandsnaamleeg!
Beoordelingleeg!
Beoordelingsgrondleeg!
Toelichtingleeg!
Publieke linkleeg!
Locatie open.minvws.nlhttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/document/VWS-WOO-08-1259977
Opgeschortleeg!
Definitief IDVWS-WOO-08-1259977
Statusleeg!
FromFilehttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo
DocumentPublicationDate6 april 2021
DocumentStatusCheckedDateleeg!
DocumentStatusCheckedResultleeg!
SourceFileTypeleeg!
Tagsleeg!
Besluitleeg!
ModifiedDate2025-09-22 08:19:41
DeletedDateleeg!
BesluitURLleeg!
CreatedDate2025-06-19 18:31:59
DocumentDownloadLinkleeg!
DigestLaatsteControleDatum2025-09-22 08:19:41

🧙 User tags

Nog geen user tags

Document attributen

TagWaardeDatum
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.5 Het voorkomen van onevenredige benadeling Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten2025-09-01 16:23:25
About_Gelakte gegevens_linkhref_3mailto:DienstpostbusDatalekkenDoo@minvws.nl2025-09-01 16:23:25
DocumentDownload_linknameDownload (pdf, 1.46 MB)2025-07-10 19:22:36
DocumentDownload_linkhrefhttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/document/1eec1b43-59ad-60ee-ae78-bb3705657b162025-07-10 19:22:36
DocumentDownload_proposed_filename (lokale kopie)VWS-WOO-08-1259977.pdf2025-07-10 19:22:36
document_SectionDownloadButton12025-07-10 19:22:36
document_SectionHistory12025-06-22 23:45:42
About_Gelakte gegevens_linkname_3Laat het ons weten2025-06-22 23:45:42
document_SectionRequest12025-06-22 23:45:42
Request_Onderdeel vanWoo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 20212025-06-22 23:45:42
Request_Onderdeel van_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo2025-06-22 23:45:42
Request_Onderdeel van_linkname_1Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 20212025-06-22 23:45:42
Request_Samenvatting verzoekDe minister van Volksgezondheid, Welzijn en Sport heeft op 23 november 2023 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties & Medicatie maart 2021.2025-06-22 23:45:42
Request_PeriodeMaart 20212025-06-22 23:45:42
Request_Type besluitWoo-besluit2025-06-22 23:45:42
Request_Datum besluit23 november 20232025-06-22 23:45:42
Request_Omvang openbaarmaking15.961 documenten, 29.047 pagina's Inventarislijst2025-06-22 23:45:42
Request_Omvang openbaarmaking_documenten15.9612025-06-22 23:45:42
Request_Omvang openbaarmaking_paginas29.0472025-06-22 23:45:42
Request_Omvang openbaarmaking_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/inventory2025-06-22 23:45:42
Request_Omvang openbaarmaking_linkname_1Inventarislijst2025-06-22 23:45:42
document_documentNameFW: HMA survey on AZ vaccine and MABs2025-06-22 23:45:42
document_documentTypeE-mailbericht2025-06-22 23:45:42
document_documentPublicationDate2021-04-062025-06-22 23:45:42
document_documentNumberVWS-WOO-08-12599772025-06-22 23:45:42
document_SectionDownloadButton02025-06-22 23:45:42
document_SectionHTMLDataDivs32025-06-22 23:45:42
document_SectionAbout12025-06-22 23:45:42
About_Datum document6 april 20212025-06-22 23:45:42
About_Type bronbestandE-mailbericht, 3 pagina's2025-06-22 23:45:42
About_Type bronbestand_paginas32025-06-22 23:45:42
About_Download alsPDF (1.46 MB)2025-06-22 23:45:42
About_Documentnummer12599772025-06-22 23:45:42
About_BeoordelingGedeeltelijke openbaarmaking2025-06-22 23:45:42
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.5 Het voorkomen van onevenredige benadeling Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten.2025-06-22 23:45:42
About_Gelakte gegevens_linkhref_1https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-22 23:45:42
About_Gelakte gegevens_linkname_15.1.2e Eerbiediging van de persoonlijke levenssfeer2025-06-22 23:45:42
About_Gelakte gegevens_linkhref_2https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-22 23:45:42
About_Gelakte gegevens_linkname_25.1.5 Het voorkomen van onevenredige benadeling2025-06-22 23:45:42
About_Gelakte gegevens_linkhref_3mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over FW: HMA survey on AZ vaccine and MABs (documentnummer 1eec1b43-59ad-60ee-ae78-bb3705657b16)2025-06-22 23:45:42
History Actie_2Bronbestand vervangen (pdf, 1.46 MB)2025-06-21 06:30:45
History Datum_330 mei 2024 18:392025-06-21 06:30:45
History Actie_3Bronbestand vervangen (pdf, 1.46 MB)2025-06-21 06:30:45
History Datum_430 mei 2024 17:082025-06-21 06:30:45
History Actie_4Bronbestand vervangen (pdf, 1.46 MB)2025-06-21 06:30:45
History Datum_530 mei 2024 16:532025-06-21 06:30:45
History Actie_5Bronbestand vervangen (pdf, 1.46 MB)2025-06-21 06:30:45
History Datum_630 mei 2024 15:202025-06-21 06:30:45
History Actie_6Bronbestand vervangen (pdf, 1.46 MB)2025-06-21 06:30:45
History Datum_730 mei 2024 15:082025-06-21 06:30:45
History Actie_7Bronbestand toegevoegd (pdf, 1.46 MB)2025-06-21 06:30:45
History Datum_230 mei 2024 19:322025-06-21 06:30:45
History Actie_1Bronbestand vervangen (pdf, 1.46 MB)2025-06-21 06:30:45
History Datum_130 mei 2024 19:362025-06-21 06:30:45

Archiefversies (6 rijen)

Archiefrij 1 — 2025-09-07 17:26:07
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1259977.pdf
documentName: VWS-WOO-08-1259977.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 1532252
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:26:07
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:26:07
lastSeen: 2025-09-07 17:26:07
text: 1259977 To: Cc: HERE @minvws. nl]; (EEE @minvws.nl] From: ) Sent: Tue 4/6/2021 11:18:46 AM Subject: FW:HMA survey onAZvaccine andMABs Received:Tue 4/6/2021 11:18:47 AM Second HMA survey (week 12).xlsx Ter info. Bevat ook info over welke landen monoclonale Abgebruiken/inkopen van:IEEE SEEM@cbg-meb.nl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 1a4f5b1ee446946b120cd66305915e080d6f2eec5ceef8c877fa80f4cab72f3f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_48274_d5ec873fa13575596d57837d4b2a99cf
textDigestSHA256: eb822017ac7a101825042b53a4dbc4da1183f807241d5e6ee6e869515a0d7571
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1259977
Archiefrij 2 — 2025-09-04 17:12:23
fromFile: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
documentName: VWS-WOO-08-1259977.pdf
documentType: pdf
documentCompressedSize: 1080186
documentSize: 1532252
documentCompressRatio: 70.49662849191908
documentDateModified: 2025-05-01 20:45:46
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:12:23
lastSeen: 2025-09-04 17:12:23
text: 1259977 To: HERE @minvws. nl]; Cc: From: (EEE @minvws.nl] ) Sent: Tue 4/6/2021 11:18:46 AM Subject: FW: HMA survey on AZ vaccine and MABs Received: Tue 4/6/2021 11:18:47 AM Second HMA survey (week 12).xlsx Ter info. Bevat ook info over welke landen monoclonale...
noTextDate: leeg!
ocrText: 1227720 Artikel ArtikeIType, ArtikelFarmaceut ArtikelDescription ArtikelCategorie ArtikelAantal ArtikelEenheid, ArtikelHoeveelheid, ArtikelHoeveelheid Flacons,ArtikelHoeveelheidDosesPerTray ArtikelHoeveelheidDoses, ArtikelAfnemer ArtikelAfnemerGroep, ArtikelAfgiftedatum , ArtikelStatus, ArtikelAfze...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 1a4f5b1ee446946b120cd66305915e080d6f2eec5ceef8c877fa80f4cab72f3f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip_6089
textDigestSHA256: 4cda687d4692b1199d6868fc8afb02b7415e0d1e0f55d632ca465570e70a94f9
ocrTextDigestSHA256: cbb318e36bc801b51a4e835f266ccf9e2f2591f7587882f9cceab6e8131f83fb
extractedId: VWS-WOO-08-1259977
Archiefrij 3 — 2025-09-04 17:10:20
fromFile: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
documentName: VWS-WOO-08-1259977.pdf
documentType: pdf
documentCompressedSize: 1080186
documentSize: 1532252
documentCompressRatio: 70.49662849191908
documentDateModified: 2025-05-01 20:45:46
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:10:20
lastSeen: 2025-09-04 17:10:20
text: 1259977 To: HERE @minvws. nl]; Cc: From: (EEE @minvws.nl] ) Sent: Tue 4/6/2021 11:18:46 AM Subject: FW: HMA survey on AZ vaccine and MABs Received: Tue 4/6/2021 11:18:47 AM Second HMA survey (week 12).xlsx Ter info. Bevat ook info over welke landen monoclonale...
noTextDate: leeg!
ocrText: isoweek-2021 isoweek-2022 |Ct-waarde 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 1a4f5b1ee446946b120cd66305915e080d6f2eec5ceef8c877fa80f4cab72f3f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip_6089
textDigestSHA256: 4cda687d4692b1199d6868fc8afb02b7415e0d1e0f55d632ca465570e70a94f9
ocrTextDigestSHA256: 34ea7743594f08b217c2e155c1f4035ef17e172d69327d310aa73507055b967b
extractedId: VWS-WOO-08-1259977
Archiefrij 4 — 2025-03-18 09:30:26
fromFile: 2024.075-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1259977-FW_HMA_survey_on_AZ_vaccine_and_MABs.pdf
documentType: pdf
documentCompressedSize: 1077867
documentSize: 1532252
documentCompressRatio: 70.34528262975019
documentDateModified: 2024-10-25 13:32:26
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:26
lastSeen: 2025-03-18 09:30:26
text: 1259977 To: Cc: HERE @minvws. nl]; (EEE @minvws.nl] From: ) Sent: Tue 4/6/2021 11:18:46 AM Subject: FW:HMA survey onAZvaccine andMABs Received:Tue 4/6/2021 11:18:47 AM Second HMA survey (week 12).xlsx Ter info. Bevat ook info over welke landen monoclonale Abgebruiken/inkopen van:IEEE SEEM@cbg-meb.nl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: eb822017ac7a101825042b53a4dbc4da1183f807241d5e6ee6e869515a0d7571
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: 356909
textDigestSHA256: eb822017ac7a101825042b53a4dbc4da1183f807241d5e6ee6e869515a0d7571
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1259977
Archiefrij 5 — 2025-02-27 09:25:06
fromFile: 2022.252-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2022.252-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1259977-FW_HMA_survey_on_AZ_vaccine_and_MABs.pdf
documentType: pdf
documentCompressedSize: 1077867
documentSize: 1532252
documentCompressRatio: 70.34528262975019
documentDateModified: 2024-10-25 13:32:26
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:06
lastSeen: 2025-02-27 09:25:06
text: 1259977 To: Cc: HERE @minvws. nl]; (EEE @minvws.nl] From: ) Sent: Tue 4/6/2021 11:18:46 AM Subject: FW:HMA survey onAZvaccine andMABs Received:Tue 4/6/2021 11:18:47 AM Second HMA survey (week 12).xlsx Ter info. Bevat ook info over welke landen monoclonale Abgebruiken/inkopen van:IEEE SEEM@cbg-meb.nl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 40, "email": "@minvws.nl", "context": "@minvws. nl]; (EEE @minvws.nl] From: ) Sent:"}, {"position": 285, "email": "SEEM@cbg-meb.nl", "context": "monoclonale Abgebruiken/inkopen van:IEEE SEEM@cbg-meb.nl> Verzonden: vrijdag 26maart"}, {"position": 340, "email": "@cbg-meb.nl", "context": "26maart 2021 13:47 @cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>;"}, {"position": 360, "email": "CHIPERS@igj.nl", "context": "2021 13:47 @cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni>"}, {"position": 389, "email": "@igj.nl", "context": "@cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni> Onderwerp: HMA"}, {"position": 399, "email": "JEEEM@cbg-meb.ni", "context": "CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni> Onderwerp: HMA survey"}, {"position": 930, "email": "@rivm.nl", "context": "19maart 2021 17:46 @rivm.nl>; 3}o 5:5.1.2e .<"}, {"position": 2277, "email": "@sukl.skJERPEN", "context": "19maart 2021 17:05 @sukl.skJERPEN <BR @bfarm.de >51.5"}, {"position": 2296, "email": "@bfarm.de", "context": "17:05 @sukl.skJERPEN <BR @bfarm.de >51.5 5.1.2e@lakemedelsverket.se>; 5.1.2e"}, {"position": 2312, "email": "5.1.2e@lakemedelsverket.se", "context": "<BR @bfarm.de >51.5 5.1.2e@lakemedelsverket.se>; 5.1.2e 5.1.5 K"}, {"position": 2356, "email": "5.1.2e@fagg-afmps.be", "context": "5.1.2e 5.1.5 K 5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER"}, {"position": 2392, "email": "5.1.2e@infarmed.pt", "context": "5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER 5.1.2e 5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI<"}, {"position": 2412, "email": "5.1.2eLA.2e@pei.de", "context": "5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER 5.1.2e 5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI<"}, {"position": 2480, "email": "5.1.2e@lakemedelsverket.se", "context": "5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI< < 5.1.2e@lakemedelsverket.se>;| 51.2e< 5.1.2e@noma.no>; 5.1.2e"}, {"position": 2517, "email": "5.1.2e@noma.no", "context": "< 5.1.2e@lakemedelsverket.se>;| 51.2e< 5.1.2e@noma.no>; 5.1.2e Dsukl.sk>; 5.1.2eH"}, {"position": 2560, "email": "5.12e@bda.bg", "context": "5.1.2e Dsukl.sk>; 5.1.2eH 5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e"}, {"position": 2575, "email": "ERFLIERER@uskvbl.cz", "context": "Dsukl.sk>; 5.1.2eH 5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>;"}, {"position": 2601, "email": "BEl@bfsa.bg", "context": "5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE"}, {"position": 2639, "email": "5.1.2e@ages.at", "context": "ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>;"}, {"position": 2656, "email": "5.1.2e@ansm.sante.fr", "context": "FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit."}, {"position": 2679, "email": "IEEREEAEAEN@aemps.es", "context": "<BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit. It>;[EEE<"}, {"position": 2708, "email": "@bfsa.bg", "context": "5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit. It>;[EEE< 5.1.2e"}, {"position": 2742, "email": "@aifa.gov.it", "context": "Gvit. It>;[EEE< 5.1.2e @aifa.gov.it> ERFEN @dgav.pt>; ."}, {"position": 2762, "email": "@dgav.pt", "context": "5.1.2e @aifa.gov.it> ERFEN @dgav.pt>; . @sukl.cz>; 5.1.2e"}, {"position": 2775, "email": "@sukl.cz", "context": "ERFEN @dgav.pt>; . @sukl.cz>; 5.1.2e CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>;"}, {"position": 2793, "email": "CALI@sanita.it", "context": ". @sukl.cz>; 5.1.2e CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>; ERE @iskvbl.sk>:"}, {"position": 2838, "email": "@iskvbl.sk", "context": "CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>; ERE @iskvbl.sk>: 1.2e \u00ae 512e"}, {"position": 2869, "email": "@icbmv.ro", "context": "\u00ae 512e SAFE @icbmv.ro. <PENFLES @phs.moh.gov.cy>; EM"}, {"position": 2889, "email": "@phs.moh.gov.cy", "context": "SAFE @icbmv.ro. <PENFLES @phs.moh.gov.cy>; EM i ravimiamet.ee>;"}, {"position": 2928, "email": "@zva.gov.lv", "context": "EM i ravimiamet.ee>; @zva.gov.lv>;1259977 meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL"}, {"position": 2964, "email": "@anses.fr", "context": "@zva.gov.lv>;1259977 meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie"}, {"position": 2985, "email": "@bfarm.de", "context": "meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie CRIB"}, {"position": 3006, "email": "@hpra.ie", "context": "@anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie CRIB WER @ms. etat."}, {"position": 3075, "email": "@ansm.sante.fr", "context": "5.1.2e 51.2e 5.1.2e @ansm.sante.fr> GESA EEN@aemps.es>; 5.1.2e"}, {"position": 3096, "email": "EEN@aemps.es", "context": "5.1.2e @ansm.sante.fr> GESA EEN@aemps.es>; 5.1.2e .<FSed} @cbg-meb.nl>;5.1.2e"}, {"position": 3126, "email": "@cbg-meb.nl", "context": "EEN@aemps.es>; 5.1.2e .<FSed} @cbg-meb.nl>;5.1.2e <BR @dkma.dk>; AWLN@"}, {"position": 3150, "email": "@dkma.dk", "context": ".<FSed} @cbg-meb.nl>;5.1.2e <BR @dkma.dk>; AWLN@ aifa.gov.it>; 51.5"}, {"position": 3190, "email": "@anm.ro", "context": "aifa.gov.it>; 51.5 AFL @anm.ro>; IEEE @eof gr>JERE]"}]
documentMailAdresses: [{"position": 40, "email": "@minvws.nl", "context": "@minvws. nl]; (EEE @minvws.nl] From: ) Sent:"}, {"position": 285, "email": "SEEM@cbg-meb.nl", "context": "monoclonale Abgebruiken/inkopen van:IEEE SEEM@cbg-meb.nl> Verzonden: vrijdag 26maart"}, {"position": 340, "email": "@cbg-meb.nl", "context": "26maart 2021 13:47 @cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>;"}, {"position": 360, "email": "CHIPERS@igj.nl", "context": "2021 13:47 @cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni>"}, {"position": 389, "email": "@igj.nl", "context": "@cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni> Onderwerp: HMA"}, {"position": 399, "email": "JEEEM@cbg-meb.ni", "context": "CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni> Onderwerp: HMA survey"}, {"position": 930, "email": "@rivm.nl", "context": "19maart 2021 17:46 @rivm.nl>; 3}o 5:5.1.2e .<"}, {"position": 2277, "email": "@sukl.skJERPEN", "context": "19maart 2021 17:05 @sukl.skJERPEN <BR @bfarm.de >51.5"}, {"position": 2296, "email": "@bfarm.de", "context": "17:05 @sukl.skJERPEN <BR @bfarm.de >51.5 5.1.2e@lakemedelsverket.se>; 5.1.2e"}, {"position": 2312, "email": "5.1.2e@lakemedelsverket.se", "context": "<BR @bfarm.de >51.5 5.1.2e@lakemedelsverket.se>; 5.1.2e 5.1.5 K"}, {"position": 2356, "email": "5.1.2e@fagg-afmps.be", "context": "5.1.2e 5.1.5 K 5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER"}, {"position": 2392, "email": "5.1.2e@infarmed.pt", "context": "5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER 5.1.2e 5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI<"}, {"position": 2412, "email": "5.1.2eLA.2e@pei.de", "context": "5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER 5.1.2e 5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI<"}, {"position": 2480, "email": "5.1.2e@lakemedelsverket.se", "context": "5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI< < 5.1.2e@lakemedelsverket.se>;| 51.2e< 5.1.2e@noma.no>; 5.1.2e"}, {"position": 2517, "email": "5.1.2e@noma.no", "context": "< 5.1.2e@lakemedelsverket.se>;| 51.2e< 5.1.2e@noma.no>; 5.1.2e Dsukl.sk>; 5.1.2eH"}, {"position": 2560, "email": "5.12e@bda.bg", "context": "5.1.2e Dsukl.sk>; 5.1.2eH 5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e"}, {"position": 2575, "email": "ERFLIERER@uskvbl.cz", "context": "Dsukl.sk>; 5.1.2eH 5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>;"}, {"position": 2601, "email": "BEl@bfsa.bg", "context": "5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE"}, {"position": 2639, "email": "5.1.2e@ages.at", "context": "ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>;"}, {"position": 2656, "email": "5.1.2e@ansm.sante.fr", "context": "FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit."}, {"position": 2679, "email": "IEEREEAEAEN@aemps.es", "context": "<BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit. It>;[EEE<"}, {"position": 2708, "email": "@bfsa.bg", "context": "5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit. It>;[EEE< 5.1.2e"}, {"position": 2742, "email": "@aifa.gov.it", "context": "Gvit. It>;[EEE< 5.1.2e @aifa.gov.it> ERFEN @dgav.pt>; ."}, {"position": 2762, "email": "@dgav.pt", "context": "5.1.2e @aifa.gov.it> ERFEN @dgav.pt>; . @sukl.cz>; 5.1.2e"}, {"position": 2775, "email": "@sukl.cz", "context": "ERFEN @dgav.pt>; . @sukl.cz>; 5.1.2e CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>;"}, {"position": 2793, "email": "CALI@sanita.it", "context": ". @sukl.cz>; 5.1.2e CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>; ERE @iskvbl.sk>:"}, {"position": 2838, "email": "@iskvbl.sk", "context": "CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>; ERE @iskvbl.sk>: 1.2e \u00ae 512e"}, {"position": 2869, "email": "@icbmv.ro", "context": "\u00ae 512e SAFE @icbmv.ro. <PENFLES @phs.moh.gov.cy>; EM"}, {"position": 2889, "email": "@phs.moh.gov.cy", "context": "SAFE @icbmv.ro. <PENFLES @phs.moh.gov.cy>; EM i ravimiamet.ee>;"}, {"position": 2928, "email": "@zva.gov.lv", "context": "EM i ravimiamet.ee>; @zva.gov.lv>;1259977 meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL"}, {"position": 2964, "email": "@anses.fr", "context": "@zva.gov.lv>;1259977 meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie"}, {"position": 2985, "email": "@bfarm.de", "context": "meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie CRIB"}, {"position": 3006, "email": "@hpra.ie", "context": "@anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie CRIB WER @ms. etat."}, {"position": 3075, "email": "@ansm.sante.fr", "context": "5.1.2e 51.2e 5.1.2e @ansm.sante.fr> GESA EEN@aemps.es>; 5.1.2e"}, {"position": 3096, "email": "EEN@aemps.es", "context": "5.1.2e @ansm.sante.fr> GESA EEN@aemps.es>; 5.1.2e .<FSed} @cbg-meb.nl>;5.1.2e"}, {"position": 3126, "email": "@cbg-meb.nl", "context": "EEN@aemps.es>; 5.1.2e .<FSed} @cbg-meb.nl>;5.1.2e <BR @dkma.dk>; AWLN@"}, {"position": 3150, "email": "@dkma.dk", "context": ".<FSed} @cbg-meb.nl>;5.1.2e <BR @dkma.dk>; AWLN@ aifa.gov.it>; 51.5"}, {"position": 3190, "email": "@anm.ro", "context": "aifa.gov.it>; 51.5 AFL @anm.ro>; IEEE @eof gr>JERE]"}]
digestSHA256: eb822017ac7a101825042b53a4dbc4da1183f807241d5e6ee6e869515a0d7571
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 270079
textDigestSHA256: eb822017ac7a101825042b53a4dbc4da1183f807241d5e6ee6e869515a0d7571
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1259977
Archiefrij 6 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
documentName: VWS-WOO-08-1259977-FW_HMA_survey_on_AZ_vaccine_and_MABs.pdf
documentType: pdf
documentCompressedSize: 1077867
documentSize: 1532252
documentCompressRatio: 70.34528262975019
documentDateModified: 2024-10-25 13:32:26
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1259977 To: Cc: HERE @minvws. nl]; (EEE @minvws.nl] From: ) Sent: Tue 4/6/2021 11:18:46 AM Subject: FW:HMA survey onAZvaccine andMABs Received:Tue 4/6/2021 11:18:47 AM Second HMA survey (week 12).xlsx Ter info. Bevat ook info over welke landen monoclonale Abgebruiken/inkopen van:IEEE SEEM@cbg-meb.nl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 40, "email": "@minvws.nl", "context": "@minvws. nl]; (EEE @minvws.nl] From: ) Sent:"}, {"position": 285, "email": "SEEM@cbg-meb.nl", "context": "monoclonale Abgebruiken/inkopen van:IEEE SEEM@cbg-meb.nl> Verzonden: vrijdag 26maart"}, {"position": 340, "email": "@cbg-meb.nl", "context": "26maart 2021 13:47 @cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>;"}, {"position": 360, "email": "CHIPERS@igj.nl", "context": "2021 13:47 @cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni>"}, {"position": 389, "email": "@igj.nl", "context": "@cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni> Onderwerp: HMA"}, {"position": 399, "email": "JEEEM@cbg-meb.ni", "context": "CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni> Onderwerp: HMA survey"}, {"position": 930, "email": "@rivm.nl", "context": "19maart 2021 17:46 @rivm.nl>; 3}o 5:5.1.2e .<"}, {"position": 2277, "email": "@sukl.skJERPEN", "context": "19maart 2021 17:05 @sukl.skJERPEN <BR @bfarm.de >51.5"}, {"position": 2296, "email": "@bfarm.de", "context": "17:05 @sukl.skJERPEN <BR @bfarm.de >51.5 5.1.2e@lakemedelsverket.se>; 5.1.2e"}, {"position": 2312, "email": "5.1.2e@lakemedelsverket.se", "context": "<BR @bfarm.de >51.5 5.1.2e@lakemedelsverket.se>; 5.1.2e 5.1.5 K"}, {"position": 2356, "email": "5.1.2e@fagg-afmps.be", "context": "5.1.2e 5.1.5 K 5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER"}, {"position": 2392, "email": "5.1.2e@infarmed.pt", "context": "5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER 5.1.2e 5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI<"}, {"position": 2412, "email": "5.1.2eLA.2e@pei.de", "context": "5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER 5.1.2e 5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI<"}, {"position": 2480, "email": "5.1.2e@lakemedelsverket.se", "context": "5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI< < 5.1.2e@lakemedelsverket.se>;| 51.2e< 5.1.2e@noma.no>; 5.1.2e"}, {"position": 2517, "email": "5.1.2e@noma.no", "context": "< 5.1.2e@lakemedelsverket.se>;| 51.2e< 5.1.2e@noma.no>; 5.1.2e Dsukl.sk>; 5.1.2eH"}, {"position": 2560, "email": "5.12e@bda.bg", "context": "5.1.2e Dsukl.sk>; 5.1.2eH 5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e"}, {"position": 2575, "email": "ERFLIERER@uskvbl.cz", "context": "Dsukl.sk>; 5.1.2eH 5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>;"}, {"position": 2601, "email": "BEl@bfsa.bg", "context": "5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE"}, {"position": 2639, "email": "5.1.2e@ages.at", "context": "ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>;"}, {"position": 2656, "email": "5.1.2e@ansm.sante.fr", "context": "FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit."}, {"position": 2679, "email": "IEEREEAEAEN@aemps.es", "context": "<BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit. It>;[EEE<"}, {"position": 2708, "email": "@bfsa.bg", "context": "5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit. It>;[EEE< 5.1.2e"}, {"position": 2742, "email": "@aifa.gov.it", "context": "Gvit. It>;[EEE< 5.1.2e @aifa.gov.it> ERFEN @dgav.pt>; ."}, {"position": 2762, "email": "@dgav.pt", "context": "5.1.2e @aifa.gov.it> ERFEN @dgav.pt>; . @sukl.cz>; 5.1.2e"}, {"position": 2775, "email": "@sukl.cz", "context": "ERFEN @dgav.pt>; . @sukl.cz>; 5.1.2e CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>;"}, {"position": 2793, "email": "CALI@sanita.it", "context": ". @sukl.cz>; 5.1.2e CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>; ERE @iskvbl.sk>:"}, {"position": 2838, "email": "@iskvbl.sk", "context": "CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>; ERE @iskvbl.sk>: 1.2e \u00ae 512e"}, {"position": 2869, "email": "@icbmv.ro", "context": "\u00ae 512e SAFE @icbmv.ro. <PENFLES @phs.moh.gov.cy>; EM"}, {"position": 2889, "email": "@phs.moh.gov.cy", "context": "SAFE @icbmv.ro. <PENFLES @phs.moh.gov.cy>; EM i ravimiamet.ee>;"}, {"position": 2928, "email": "@zva.gov.lv", "context": "EM i ravimiamet.ee>; @zva.gov.lv>;1259977 meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL"}, {"position": 2964, "email": "@anses.fr", "context": "@zva.gov.lv>;1259977 meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie"}, {"position": 2985, "email": "@bfarm.de", "context": "meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie CRIB"}, {"position": 3006, "email": "@hpra.ie", "context": "@anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie CRIB WER @ms. etat."}, {"position": 3075, "email": "@ansm.sante.fr", "context": "5.1.2e 51.2e 5.1.2e @ansm.sante.fr> GESA EEN@aemps.es>; 5.1.2e"}, {"position": 3096, "email": "EEN@aemps.es", "context": "5.1.2e @ansm.sante.fr> GESA EEN@aemps.es>; 5.1.2e .<FSed} @cbg-meb.nl>;5.1.2e"}, {"position": 3126, "email": "@cbg-meb.nl", "context": "EEN@aemps.es>; 5.1.2e .<FSed} @cbg-meb.nl>;5.1.2e <BR @dkma.dk>; AWLN@"}, {"position": 3150, "email": "@dkma.dk", "context": ".<FSed} @cbg-meb.nl>;5.1.2e <BR @dkma.dk>; AWLN@ aifa.gov.it>; 51.5"}, {"position": 3190, "email": "@anm.ro", "context": "aifa.gov.it>; 51.5 AFL @anm.ro>; IEEE @eof gr>JERE]"}]
documentMailAdresses: [{"position": 40, "email": "@minvws.nl", "context": "@minvws. nl]; (EEE @minvws.nl] From: ) Sent:"}, {"position": 285, "email": "SEEM@cbg-meb.nl", "context": "monoclonale Abgebruiken/inkopen van:IEEE SEEM@cbg-meb.nl> Verzonden: vrijdag 26maart"}, {"position": 340, "email": "@cbg-meb.nl", "context": "26maart 2021 13:47 @cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>;"}, {"position": 360, "email": "CHIPERS@igj.nl", "context": "2021 13:47 @cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni>"}, {"position": 389, "email": "@igj.nl", "context": "@cbg-meb.nl>;5.1.2e CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni> Onderwerp: HMA"}, {"position": 399, "email": "JEEEM@cbg-meb.ni", "context": "CHIPERS@igj.nl>; 5.1.2e )<BR]@igj.nl>; JEEEM@cbg-meb.ni> Onderwerp: HMA survey"}, {"position": 930, "email": "@rivm.nl", "context": "19maart 2021 17:46 @rivm.nl>; 3}o 5:5.1.2e .<"}, {"position": 2277, "email": "@sukl.skJERPEN", "context": "19maart 2021 17:05 @sukl.skJERPEN <BR @bfarm.de >51.5"}, {"position": 2296, "email": "@bfarm.de", "context": "17:05 @sukl.skJERPEN <BR @bfarm.de >51.5 5.1.2e@lakemedelsverket.se>; 5.1.2e"}, {"position": 2312, "email": "5.1.2e@lakemedelsverket.se", "context": "<BR @bfarm.de >51.5 5.1.2e@lakemedelsverket.se>; 5.1.2e 5.1.5 K"}, {"position": 2356, "email": "5.1.2e@fagg-afmps.be", "context": "5.1.2e 5.1.5 K 5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER"}, {"position": 2392, "email": "5.1.2e@infarmed.pt", "context": "5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER 5.1.2e 5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI<"}, {"position": 2412, "email": "5.1.2eLA.2e@pei.de", "context": "5.1.2e@fagg-afmps.be>; 5.1.5 5.1.2e 5.1.2e@infarmed.pt>;5.1.2eLA.2e@pei.de>;BECKER 5.1.2e 5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI<"}, {"position": 2480, "email": "5.1.2e@lakemedelsverket.se", "context": "5.1.2e5.1.2eI<Dgov.mt> 5.1.2eI< < 5.1.2e@lakemedelsverket.se>;| 51.2e< 5.1.2e@noma.no>; 5.1.2e"}, {"position": 2517, "email": "5.1.2e@noma.no", "context": "< 5.1.2e@lakemedelsverket.se>;| 51.2e< 5.1.2e@noma.no>; 5.1.2e Dsukl.sk>; 5.1.2eH"}, {"position": 2560, "email": "5.12e@bda.bg", "context": "5.1.2e Dsukl.sk>; 5.1.2eH 5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e"}, {"position": 2575, "email": "ERFLIERER@uskvbl.cz", "context": "Dsukl.sk>; 5.1.2eH 5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>;"}, {"position": 2601, "email": "BEl@bfsa.bg", "context": "5.12e@bda.bg>; ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE"}, {"position": 2639, "email": "5.1.2e@ages.at", "context": "ERFLIERER@uskvbl.cz>; FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>;"}, {"position": 2656, "email": "5.1.2e@ansm.sante.fr", "context": "FH <BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit."}, {"position": 2679, "email": "IEEREEAEAEN@aemps.es", "context": "<BEl@bfsa.bg>;A.5.1.2eWaemps.es>;51.2e 5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit. It>;[EEE<"}, {"position": 2708, "email": "@bfsa.bg", "context": "5.1.2e@ages.at>; 5.1.2e@ansm.sante.fr>; IEEREEAEAEN@aemps.es>;EREKRE @bfsa.bg>; Gvit. It>;[EEE< 5.1.2e"}, {"position": 2742, "email": "@aifa.gov.it", "context": "Gvit. It>;[EEE< 5.1.2e @aifa.gov.it> ERFEN @dgav.pt>; ."}, {"position": 2762, "email": "@dgav.pt", "context": "5.1.2e @aifa.gov.it> ERFEN @dgav.pt>; . @sukl.cz>; 5.1.2e"}, {"position": 2775, "email": "@sukl.cz", "context": "ERFEN @dgav.pt>; . @sukl.cz>; 5.1.2e CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>;"}, {"position": 2793, "email": "CALI@sanita.it", "context": ". @sukl.cz>; 5.1.2e CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>; ERE @iskvbl.sk>:"}, {"position": 2838, "email": "@iskvbl.sk", "context": "CALI@sanita.it>; Ze=5.1.2eDurpl.gov.pl>; ERE @iskvbl.sk>: 1.2e \u00ae 512e"}, {"position": 2869, "email": "@icbmv.ro", "context": "\u00ae 512e SAFE @icbmv.ro. <PENFLES @phs.moh.gov.cy>; EM"}, {"position": 2889, "email": "@phs.moh.gov.cy", "context": "SAFE @icbmv.ro. <PENFLES @phs.moh.gov.cy>; EM i ravimiamet.ee>;"}, {"position": 2928, "email": "@zva.gov.lv", "context": "EM i ravimiamet.ee>; @zva.gov.lv>;1259977 meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL"}, {"position": 2964, "email": "@anses.fr", "context": "@zva.gov.lv>;1259977 meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie"}, {"position": 2985, "email": "@bfarm.de", "context": "meb.nl> 5.1.2\u00a2 @anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie CRIB"}, {"position": 3006, "email": "@hpra.ie", "context": "@anses.fr>:[RIED5AFL @bfarm.de>IIE 5.1.2e @hpra.ie CRIB WER @ms. etat."}, {"position": 3075, "email": "@ansm.sante.fr", "context": "5.1.2e 51.2e 5.1.2e @ansm.sante.fr> GESA EEN@aemps.es>; 5.1.2e"}, {"position": 3096, "email": "EEN@aemps.es", "context": "5.1.2e @ansm.sante.fr> GESA EEN@aemps.es>; 5.1.2e .<FSed} @cbg-meb.nl>;5.1.2e"}, {"position": 3126, "email": "@cbg-meb.nl", "context": "EEN@aemps.es>; 5.1.2e .<FSed} @cbg-meb.nl>;5.1.2e <BR @dkma.dk>; AWLN@"}, {"position": 3150, "email": "@dkma.dk", "context": ".<FSed} @cbg-meb.nl>;5.1.2e <BR @dkma.dk>; AWLN@ aifa.gov.it>; 51.5"}, {"position": 3190, "email": "@anm.ro", "context": "aifa.gov.it>; 51.5 AFL @anm.ro>; IEEE @eof gr>JERE]"}]
digestSHA256: eb822017ac7a101825042b53a4dbc4da1183f807241d5e6ee6e869515a0d7571
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 59215
textDigestSHA256: eb822017ac7a101825042b53a4dbc4da1183f807241d5e6ee6e869515a0d7571
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1259977
Nieuw document zoeken

(dit is ook een speeltuin)